Biomarker overview
BRAF V600E
Synonyms: BRAF V600E
Tumor-type contexts
Context map
| Tumor type | Drug context | Role | Strategy | Context page |
|---|---|---|---|---|
| colorectal cancer | Small Molecule Inhibitor | Inclusion Required | Manual Review Required | Open |
| colorectal cancer | Immune Checkpoint Inhibitor | Inclusion Required | Low Public Signal | Open |
| colorectal cancer | Combination Therapy | Inclusion Required | Manual Review Required | Open |
| melanoma | Combination Therapy | Inclusion Required | Low Public Signal | Open |
| melanoma | Therapy Not Normalized | Inclusion Required | Drug Development Ahead Of Cdx Context | Open |
| NSCLC | Immune Checkpoint Inhibitor | Inclusion Required | Trial Selection Rising | Open |
| breast cancer | Immune Checkpoint Inhibitor | Inclusion Required | Low Public Signal | Open |
| melanoma | Small Molecule Inhibitor | Inclusion Required | Drug Development Ahead Of Cdx Context | Open |
| colorectal cancer | Therapy Not Normalized | Inclusion Required | Trial Selection Rising | Open |
| NSCLC | Therapy Not Normalized | Inclusion Required | Trial Selection Rising | Open |
| solid tumor basket | Therapy Not Normalized | Inclusion Required | Trial Selection Rising | Open |
| NSCLC | Combination Therapy | Inclusion Required | Trial Selection Rising | Open |
| melanoma | Immune Checkpoint Inhibitor | Inclusion Required | Drug Development Ahead Of Cdx Context | Open |
| ovarian cancer | Therapy Not Normalized | Mention Only | Exploratory Only Signal | Open |
| gastric cancer | Therapy Not Normalized | Inclusion Required | Low Public Signal | Open |
| ovarian cancer | Small Molecule Inhibitor | Inclusion Required | Low Public Signal | Open |
| NSCLC | Small Molecule Inhibitor | Inclusion Required | Manual Review Required | Open |
| solid tumor basket | Monoclonal Antibody | Treatment Assignment | Manual Review Required | Open |
| solid tumor basket | Small Molecule Inhibitor | Inclusion Required | Drug Development Ahead Of Cdx Context | Open |
| solid tumor basket | Combination Therapy | Inclusion Required | Drug Development Ahead Of Cdx Context | Open |
| NSCLC | Monoclonal Antibody | Inclusion Required | Trial Selection Rising | Open |
| colorectal cancer | Monoclonal Antibody | Inclusion Required | Trial Selection Rising | Open |
| colorectal cancer | ADC | Mention Only | Exploratory Only Signal | Open |
| pancreatic cancer | Combination Therapy | Mention Only | Exploratory Only Signal | Open |
| ovarian cancer | Immune Checkpoint Inhibitor | Inclusion Required | Low Public Signal | Open |
| NSCLC | ADC | Inclusion Required | Low Public Signal | Open |
| solid tumor basket | Immune Checkpoint Inhibitor | Inclusion Required | Low Public Signal | Open |
| breast cancer | Monoclonal Antibody | Inclusion Required | Low Public Signal | Open |
| gastric cancer | Small Molecule Inhibitor | Inclusion Required | Low Public Signal | Open |
| gastric cancer | Immune Checkpoint Inhibitor | Inclusion Required | Low Public Signal | Open |
| gastric cancer | Combination Therapy | Inclusion Required | Low Public Signal | Open |